Literature DB >> 33255227

MicroRNA, Diabetes Mellitus and Colorectal Cancer.

Hsiuying Wang1.   

Abstract

Diabetes mellitus (DM) is an endocrinological disorder that is due to either the pancreas not producing enough insulin, or the body does not respond appropriately to insulin. There are many complications of DM such as retinopathy, nephropathy, and peripheral neuropathy. In addition to these complications, DM was reported to be associated with different cancers. In this review, we discuss the association between DM and colorectal cancer (CRC). CRC is the third most commonly diagnosed cancer worldwide that mostly affects older people, however, its incidence and mortality are rising among young people. We discuss the relationship between DM and CRC based on their common microRNA (miRNA) biomarkers. miRNAs are non-coding RNAs playing important functions in cell differentiation, development, regulation of cell cycle, and apoptosis. miRNAs can inhibit cell proliferation and induce apoptosis in CRC cells. miRNAs also can improve glucose tolerance and insulin sensitivity. Therefore, investigating the common miRNA biomarkers of both DM and CRC can shed a light on how these two diseases are correlated and more understanding of the link between these two diseases can help the prevention of both DM and CRC.

Entities:  

Keywords:  biomarkers; colorectal cancer; diabetes mellitus; glucose; insulin; microRNA

Year:  2020        PMID: 33255227      PMCID: PMC7760221          DOI: 10.3390/biomedicines8120530

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  173 in total

1.  miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer.

Authors:  Guanli Huang; Xiangjian Chen; Yefeng Cai; Xiaobo Wang; Chungen Xing
Journal:  Oncol Rep       Date:  2016-11-28       Impact factor: 3.906

2.  miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway.

Authors:  Sinan Sun; Tianyi Hang; Boyu Zhang; Liang Zhu; Yang Wu; Xiangwei Lv; Qiang Huang; Hanhui Yao
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 3.  MicroRNA and cancer.

Authors:  Martin D Jansson; Anders H Lund
Journal:  Mol Oncol       Date:  2012-10-09       Impact factor: 6.603

4.  Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer.

Authors:  W M Grady; R K Parkin; P S Mitchell; J H Lee; Y-H Kim; K D Tsuchiya; M K Washington; C Paraskeva; J K V Willson; A M Kaz; E M Kroh; A Allen; B R Fritz; S D Markowitz; M Tewari
Journal:  Oncogene       Date:  2008-02-11       Impact factor: 9.867

5.  Inhibition of miR-200c Restores Endothelial Function in Diabetic Mice Through Suppression of COX-2.

Authors:  Huina Zhang; Jian Liu; Dan Qu; Li Wang; Jiang-Yun Luo; Chi Wai Lau; Pingsheng Liu; Zhen Gao; George L Tipoe; Hung Kay Lee; Chi Fai Ng; Ronald Ching Wan Ma; Xiaoqiang Yao; Yu Huang
Journal:  Diabetes       Date:  2016-01-28       Impact factor: 9.461

Review 6.  Role of microRNA 21 in diabetes and associated/related diseases.

Authors:  Durairaj Sekar; Basam Venugopal; Punitha Sekar; Krishnan Ramalingam
Journal:  Gene       Date:  2016-01-27       Impact factor: 3.688

7.  Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells.

Authors:  Haruo Nakano; Tatsuya Miyazawa; Keita Kinoshita; Yoji Yamada; Tetsuo Yoshida
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

Review 8.  Obesity, Insulin Resistance, and Colorectal Cancer: Could miRNA Dysregulation Play A Role?

Authors:  Francesca Cirillo; Cecilia Catellani; Chiara Sartori; Pietro Lazzeroni; Sergio Amarri; Maria Elisabeth Street
Journal:  Int J Mol Sci       Date:  2019-06-14       Impact factor: 5.923

9.  Altered microRNA profile during fracture healing in rats with diabetes.

Authors:  Shunsuke Takahara; Sang Yang Lee; Takashi Iwakura; Keisuke Oe; Tomoaki Fukui; Etsuko Okumachi; Michio Arakura; Yoshitada Sakai; Tomoyuki Matsumoto; Takehiko Matsushita; Ryosuke Kuroda; Takahiro Niikura
Journal:  J Orthop Surg Res       Date:  2020-04-07       Impact factor: 2.359

Review 10.  MicroRNAs and Apoptosis in Colorectal Cancer.

Authors:  Hsiuying Wang
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

View more
  4 in total

Review 1.  Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications.

Authors:  Milad Ashrafizadeh; Alan Prem Kumar; Amir Reza Aref; Ali Zarrabi; Ebrahim Mostafavi
Journal:  Int J Nanomedicine       Date:  2022-03-19

2.  COVID-19, Anti-NMDA Receptor Encephalitis and MicroRNA.

Authors:  Hsiuying Wang
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

3.  miR-22 Suppresses EMT by Mediating Metabolic Reprogramming in Colorectal Cancer through Targeting MYC-Associated Factor X.

Authors:  Shusen Xia; Xianyan Wang; Yi Wu; Tong Zhou; Hongpeng Tian; Zuoliang Liu; Lifa Li; Zaihua Yan; Guangjun Zhang
Journal:  Dis Markers       Date:  2022-08-25       Impact factor: 3.464

4.  Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model.

Authors:  Edina Pandur; István Szabó; Edina Hormay; Ramóna Pap; Attila Almási; Katalin Sipos; Viktória Farkas; Zoltán Karádi
Journal:  Diabetol Metab Syndr       Date:  2022-10-10       Impact factor: 5.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.